Industry reports
Editor highlights

Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)

Kalorama Information
  • Publication date: June 2011
  • Report price: $ 4 200

Get this report today!

$ 4 200 - 1 User License
$ 6 200 - Department License
$ 8 400 - Corporate License

Summary

Table of Contents

Data Series

There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the in IVD industry as it applies to emerging markets and the BRIC countries in particular.


A Realistic Look at the Market for IVD in New, Emerging Markets


A good number of reports on the BRIC and emerging markets have been published. Most of these focus on quantitative data such as number of labs, hospitals, product registration regulations, and import taxes and conditions. Too many of them perhaps present merely a growth scenario without presenting the challenges the nations face and the challenges the countries face entering the market. This report provides much of this information because it provides an objective overview of the market for in vitro diagnostics in selected countries. This report also explores the opportunities that specific developing countries offer to IVD companies.


Kalorama also attempts to add some realistic aspects of working in a foreign country that are more qualitative in nature. Thus the report explores some of the cultural aspects of how the market for clinical diagnostics may evolve in a selection of emerging markets including the BRIC countries.


Useful Information for Business Planning


The discussion of each of the BRIC markets begins with a short introduction to the country and follows with a SWOT analysis of the market for IVDs. The SWOT analysis provides positive and negative aspects of market conditions. The author has decided to include positive and negative aspects of certain factors in the same SWOT category. The factors are classed positive or negative according to the strength of current market conditions. This is done to make the analysis comprehensive and easier to read.



The report covers data trends and issues, including:


  • Healthcare trends and metrics in each country

  • Physician Office Testing (POL) in BRIC Countries

  • Disease Trends (Diabetes, Cancer, Allergy, Emerging Viruses)

  • Lab Systems in BRIC Countries

  • SWOT Analysis for Each BRIC Nation, Including:

    • Strengths - factors that make the country attractive for IVD companies

    • Weaknesses that form barriers to entry and success such as health insurance coverage, regulatory affairs and distribution issues

    • Country Elements that Provide Testing Opportunities

    • Threats - a look at the competition and incumbents


  • Key Companies Operating in Each Country

  • Research and High Technology in BRIC countries

  • Other Trends (Insurance, Medical Tourism, Recession Effects )


Market and economic trends are discussed from the point of view of their present and potential impact and there is a focus on the mix of economics, healthcare and diagnostics that may evolve in these countries.

Kalorama Information
  • Publication date: June 2011
  • Report price: $ 4 200

Get this report today!

$ 4 200 - 1 User License
$ 6 200 - Department License
$ 8 400 - Corporate License

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

In Vitro Diagnostic Industry in Russian Federation : Latest Reports

2014 Projected Global Laboratory Products Budgets

2014 Projected Global Laboratory Products Budgets

  • $ 10 000
  • Industry report
  • January 2014
  • by Frost & Sullivan

Brands Evaluated, Purchasing Trends Identified The primary aim of this study is to establish the size of laboratory budgets for the purchasing of products in 7 categories and the baselines for developing ...

2014 Current and Emerging Suppliers Of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

2014 Current and Emerging Suppliers Of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

  • $ 8 500
  • Industry report
  • January 2014
  • by Venture Planning Group

This new report from Venture Planning Group provides analyses of current and emerging suppliers of immunodiagnositc, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood ...

World Cancer Diagnostics Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

World Cancer Diagnostics Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

  • $ 7 500
  • Industry report
  • January 2014
  • by Venture Planning Group

This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.